<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Albania</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Albania.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/al.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Sat, 07 Nov 2026 03:45:11 GMT</lastBuildDate>
  <item>
    <title>Population pharmacokinetics modeling of albendazole and its active metabolite, albendazole sulfoxide in mass drug administration against lymphatic filariasis</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1128-aac-00562-26-54a715c1/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1128-aac-00562-26-54a715c1/</guid>
    <pubDate>Wed, 04 Nov 2026 00:00:00 GMT</pubDate>
    <description>The abstract states this is the first population PK model of albendazole and albendazole sulfoxide in LF-endemic populations, and suggests sex is a key covariate explaining variability in metabolite exposure, which may inform optimized dosing in MDA programs.</description>
    <category>Filariasis</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Disclosing pathogenic processes of monkeypox (MPOX) and drug repurposing through host-transcriptomics analysis</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014797-58fd9268/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014797-58fd9268/</guid>
    <pubDate>Fri, 16 Oct 2026 00:00:00 GMT</pubDate>
    <description>With no approved MPOX drug and limited vaccine coverage, the identified candidates may inform future diagnosis and therapy efforts.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Assessing the efficacy of high-dose rifampicin plus albendazole against onchocerciasis</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014594-318f42a6/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014594-318f42a6/</guid>
    <pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate>
    <description>Albendazole monotherapy may serve as an alternative or add-on to ivermectin for reducing microfilariae in endemic areas where infection persists despite mass drug administration.</description>
    <category>Filariasis</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Risk assessment of West Nile fever in equines in Europe based on an ecological niche model.</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12917-026-05298-x-e75335a5/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12917-026-05298-x-e75335a5/</guid>
    <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
    <description>As a zoonotic disease with cross-sector impacts, the results may guide targeted monitoring and allocation of resources across human and animal health sectors.</description>
    <category>West Nile virus</category>
    <category>Surveillance</category>
    <category>Climate and environment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Crimean-Congo hemorrhagic fever: An emerging threat in Europe.</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-virs-2025-12-006-d7b8054a/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-virs-2025-12-006-d7b8054a/</guid>
    <pubDate>Mon, 15 Dec 2025 00:00:00 GMT</pubDate>
    <description>The resulting at-risk inventory may guide agencies in initiating or upgrading monitoring efforts where gaps exist.</description>
    <category>Hemorrhagic Fever</category>
    <category>Crimean-Congo hemorrhagic fever</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1093-cid-civ829-f1d588a0/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1093-cid-civ829-f1d588a0/</guid>
    <pubDate>Fri, 25 Sep 2015 00:00:00 GMT</pubDate>
    <description>The findings may help health programs identify groups missed by mass drug administration and guide targeted outreach to improve coverage. The authors particularly emphasize people of low socioeconomic status and members of minority religions or tribes.</description>
    <category>Schistosomiasis</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
